Transferrin receptor 1 upregulation in primary tumor and downregulation in benign kidney is associated with progression and mortality in renal cell carcinoma patients
Christopher Greene(Roswell Park Comprehensive Cancer Center), Eric Kauffman(Roswell Park Comprehensive Cancer Center)
Cited by 88
Related Papers
Preclinical efficacy of dual mTORC1/2 inhibitor AZD8055 in renal cell carcinoma harboring a TFE3 gene fusion
|BMC Cancer|2019|30
Suppressive effects of iron chelation in clear cell renal cell carcinoma and their dependency on VHL inactivation
|Free Radical Biology and Medicine|2018|22